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Carbon nanotubes (CNTs) are among the most relevant engineered nanomaterials (ENMs). Given the expected rise of exposure to
ENMs, there is concern that they may adversely affect health of exposed people. Aim of the study was to test the hypothesis that
single wall carbon nanotubes (SWCNTs) pulmonary exposure acutely affect the autonomic cardiovascular regulation in conscious
rats. We studied Wistar-Kyoto rats in which a telemetry transmitter for continuous arterial pressure (AP) and heart rate (HR)
recordings was surgically implanted. SWCNTs dispersed in phosphate buffer saline (PBS) or PBS alone were randomly adminis-
tered intratracheally. Immediately before, and 24 hours after each instillation a 30 min AP recording was performed. The sequence
analysis was performed to evaluate the baroreflex function. In the control group, PBS instillation did not induce any significant
changes. At variance the SWCNT exposure induced a significant reduction of baroreflex system (BRS) (3.5 ± 0.6 versus 2.6 ±
0.40msec/mmHg) without significant changes in the occurrence of baroreflex sequences (7.5 ± 0.47% versus 7.4 ± 0.38%). Our
results show that SWCNT pulmonary exposure might affect the cardiovascular autonomic regulation thus contributing to cardiac
and arrhythmic events.
1. Introduction
There is strong evidence that episodic high levels of airborne
particulate matter (PM) are associated with stroke, heart
attacks, heart arrhythmias, and sudden death [1]; these
events may be precipitated, at least in part, by alterations in
the autonomic input to the heart [2–5], which can be dis-
played by a partial or total loss in spontaneous heart rate
variability (HRV). Indeed, decreased HRV is highly pre-
dictive for increased risk of arrythmias and sudden cardiac
death [6], especially in subjects with ischemic heart disease
[7].
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There are also reports showing that higher levels of ambi-
ent air pollutants increase the risk of emergency department
(ED) visits for cardiac arrhythmia [8]. Moreover it has been
suggested that alterations in the autonomic tone eventually
due to increased environment air pollution might contribute
to the instability of a vascular plaque or initiate cardiac ar-
rhythmias thus representing a plausible explanation for the
occurrence of acute cardiovascular events, such as increased
myocardial infarctions [9].
However, previous studies on PM have shown that
ultrafine (UF) particles are more cytotoxic, inflammatory,
and fibrogenic on an equivalent mass basis than fine-sized
particles of the same composition. It is therefore not surpris-
ing that a recent large European study showed that the ultra-
fine (UF) component of PM is the major factor contributing
to the alterations of cardiovascular autonomic control [10].
The responsible underlying mechanisms remain unclear but
may involve activation of pulmonary neural reflex arcs,
direct effects of pollutants on cerebral areas responsible for
autonomic control or on cardiac ion channels, or may follow
the heightened systemic inflammatory state.
Synthetic nanomaterials, developed in recent years to
engineer new structures, materials, and devices, generally
occur in size ranges similar to UF particles. An important
class of synthetic nanomaterials is represented by carbon
nanotubes. These cylindrical carbon molecules have novel
properties, making them potentially useful in many applica-
tions in nanotechnology, electronics, optics, and other fields
of materials science, as well as potential uses in architectural
fields. Therefore, their wide utilization raises concern about
possible adverse effects on cardiovascular system. Indeed,
some preliminary animal data suggest that carbon nanotubes
may promote atherosclerosis [11].
No definitive data are currently available on their possible
effects on the cardiovascular autonomic control.
The introduction of techniques able to monitor arterial
pressure and heart rate in conscious, freely moving animals
allows to evaluate possible modifications of autonomic car-
diovascular regulation over time in response to various expe-
rimental conditions [12]. In particular, the possibility to
monitor the baroreflex control of sinus node by studying the
baroreflex sensitivity (BRS), in a noninvasive and nonobtru-
sive way [13], is really intriguing due to its prognostic value
in cardiovascular diseases [14, 15].
Therefore aim of the present study was to test the hypo-
thesis that single wall carbon nanotubes (SWCNTs) pul-
monary exposure in a physiological model of conscious rat
acutely affect the autonomic cardiovascular regulation and
in particular the arterial baroreflex function which has been
widely considered as a predictive index of cardiac mortality
in patients affected by ischemic heart disease and myocardial
infarction [14, 15].
2. Material and Methods
2.1. SWCNT Preparation. SWCNTs (CarboLex, Aldrich,
Steinheim, Germany) produced by the arc-discharge process,
employing CO in a continuous-flow gas phase as the carbon
Figure 1: Scanning electron microscopy imaging of SWCNTs
administered to rats. A high degree of agglomeration is evidenced.
feedstock and Fe(CO)5 as the iron-containing catalyst pre-
cursor and purified by the HNO3 acid treatment at room
temperature, were used in this study. For the SWCNTs mor-
phological and structural characterization, Raman spec-
troscopy and scanning electron microscopy (SEM) were rou-
tinely used to characterize the as-received nanotube samples
and the samples submitted to the purification processing
steps. The Raman spectroscopy revealed a typical spectrum
associated with the radial breathing mode (RBM) of carbon
atoms, representing the fingerprint of single-walled carbon
nanotubes. The analysis of the Raman signals in the tangen-
tial modes of the graphite lattice allowed information about
the phase purity of the purified carbon nanotubes. This last
showed a Raman spectrum unaffected by the acidic treat-
ments.
2.2. Physicochemical Characterization. Purified suspended
SWCNTs were used in the study at the final concentration of
1mg/mL. The range of diameter and length and surface area
of SWCNTs were 1.2–1.6 nm, 2–5 µm, and 300m2/g, respec-
tively. Surface area was determined by Brunauer, Emmett,
and Teller analysis (BET method). Carbon nanotubes were
suspended in phosphate-buffered saline (0,1M PBS, pH 7.4);
immediately before the pulmonary exposure, they were soni-
cated for 10 minutes with a Branson Sonifier B-12 (Cell Dis-
ruptor, Sonic Power Company Danbury Connecticut at
100W) in order to obtain a better dispersion of the nano-
material. The choice to disperse SWCNTs in PBS was taken
in order to reproduce the same experimental conditions of
a previous relevant study showing a proatherosclerotic effect
after intratracheal instillation of SWCNTs [11]; the 10min
sonication procedure was chosen because in preliminary
experiments we found that after 10min sonication, the dis-
persion remained stable up to 1min. However, as shown in
Figure 1, a high degree of agglomeration was detectable at
scanning electron microscopy. During all the instillation
experiments, the purified SWCNT dispersion was subjected
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Figure 2: Examples of the arterial pressure, ECG signals and of the corresponding pulse intervals. The signals refer to sequences during which
SAP and PI of the fifth heart beat (i.e., lag 5, used for the high heart rate of rats, see Section 2 for details) changed in the same direction,
either increasing, hypertension/bradycardia, or decreasing, hypotension/tachycardia (baroreflex sequences).
to the ultrasonic bath (LBS2, 135W) for 10 minutes, and
instilled intratracheally within 1 minute after sonication, to
ensure stability of the homogeneous SWCNT dispersion. The
amount of SWCNTs given during each session was 1 µg/gr
body weight. This concentration is in the lower range of
the dosage given in previous experimental studies aimed at
assessing lung and cardiovascular toxicology of SWCNTs [11,
16, 17].
2.2.1. General Procedures. The study was performed on 16
adult Wistar-Kyoto (WKY) rats of both sexes (350 g bodywt)
and the experimental procedures were carried out accord-
ing to the Association for Assessment and Accreditation of
Laboratory Care International and approved by the animal
care facility (Stazione per la Tecnologia Animale) of the
University “Tor Vergata” and by the Italian Health Minister.
Rats were used and housed individually in the animal care
facility, allowed to normal rat chow and drinking water ad
libitum, and kept on a 12 h light-12 h dark cycle.
2.2.2. Surgical Procedures. As previously described [13], after
having induced the anesthesia by Ketamine (Ketavet 50
60mg/kg i.p.) and Medetomidine (Domitor 0.3mg/kg i.p.) a
telemetry transmitter (TA11PA-C40, Data Sciences, St. Paul,
MN, USA) was implanted for recordings of AP signals ac-
cording tomanufacturer specifications. The tip of the arterial
catheter was inserted into the abdominal aorta previously
exposed by a midline incision via a hole made by a 21-gauge
needle below the bifurcation of the renal arteries just proxi-
mal to the iliac bifurcation and secured in place with tissue
glue (Vetbond, 3M). The transmitter body was attached to
the abdominal wall along the incision line with sutures as
the incision was closed. After surgery, the rats were given
antibiotics (ceftriaxone) and housed individually in cages for
5–7 days of recovery before any experimental protocol began.
2.2.3. Measurement of Arterial Pressure Using Radiotelemetry.
As previously reported [13] the system used to record arterial
pressure consists of three basic elements: (1) a transmitter for
monitoring BP (TA11PAC40); (2) a receiver (RPC-1); (3) an
adapter (R11CPA) with an ambient pressure monitor (APR-
1) that produces analog output signals of pulsatile AP. The
telemetered AP signal was digitized using an analog I/O PC
card (National Instrument 6024E, Austin, TX, USA) at a rate
of 2000Hz, displayed on the computer screen and processed
by an algorithm based on feature extraction to detect and
measure the characteristics of AP cycles developed in our lab-
oratory based on a Lab view platform software. Pulse inter-
val (PI) was measured from the pressure pulses and used to
calculate heart rate (HR).
2.2.4. Experimental Protocol. Rats were randomly divided
into two groups: control rats (n = 7) and SWCNT instilled
rats (n = 9). SWCNTs or PBS were given to SWCNT instilled
and control group, respectively. Briefly, after having induced
the anesthesia as previously described, the trachea was intu-
bated with a polyethylene cannula of the same diameter and
the instillation was performed. Rats in both groups under-
went 30min duration AP recordings performed in baseline
conditions and 24 hours after the instillation.
2.3. Baroreflex Analysis by “Sequence Technique”. The sequ-
ence analysis was performed as previously reported [13, 18].
Briefly, the beat-by-beat time series of systolic arterial pres-
sure (SAP) and PI were analyzed by a computer to identify
spontaneously occurring sequences of three or more con-
secutive beats in which SAP and PI of the fifth heart beat
(i.e., lag 5, used for the high heart rate of rats) [19] changed
in the same direction, for example, SAP increasing and
PI increasing (i.e., hypertension and bradycardia) or SAP
decreasing and PI decreasing (i.e., hypotension and tachy-
cardia). These sequences were identified as “baroreflex”
sequences (Figure 2). A linear regression was applied to each
individual sequence, similarly to the Oxford technique
employing bolus injections of vasoactive drugs. Only those
sequences in which r2 was >0.85 were accepted and the
number of baroreflex sequences was calculated.
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The mean individual slope of the baroreflex sequences,
obtained by averaging all slopes computed within a given
experimental period, was calculated and taken as a measure
of the baroreflex sensitivity (BRS) for that period [18].
The engagement time was also calculated as the fractional
occurrence of the sequences independently on recording
time and/or HR as previously reported [13]. Briefly, this
index has been obtained by dividing the sum of the R-R
organized in sequences, according to the criteria reported
above, by the total recording duration and multiplying it by
100.
2.4. Power Spectral Analysis. The heart rate variability (HRV)
was assessed in the frequency domain by computing the
power spectral density (PSD) in selected frequency bands.
As expected, dealing with conscious and freely moving
animals, the 30min RR recordings showed periods of non-
stationarities both in mean and standard deviations. To com-
ply with the requirements of the analysis we first processed all
the recordings to extract stationary epochs (in weak sense).
To this aim amixed, automatic and visual, procedure was ap-
plied. First, mean, standard deviation (SD) and slope of the
linear trend were computed over nonoverlapping intervals
of 1min spanning the whole recording. The selection of
stationary intervals was then performed by visual inspection
of the time course of mean, SD, and slope values. Stationary
intervals of different lengths were detected inside the record-
ings: for uniformity of analysis a 5min stationary interval
was selected for each animal.
Spectral estimation was performed using Welch’s aver-
aged modified periodogram method with a Hamming win-
dow and a minimum of 50% epochs overlap. The variable
overlap comes from the choice of having, for each animal, at
least a preset minimum number of epochs to average. PSD
was assessed in the frequency range of 0.2–6Hz involving
very low frequency (VLF: from 0 to 0.2Hz), low frequency
(LF: from 0.2 to 0.6Hz), and high frequency (HF: from 0.6
to 3.0Hz) spectral bands [20]. According to the literature, the
PSD values VLFn, LFn, and HFn, expressed in normalized
units, are obtained as the ratio between the VLF, LF, and
HF powers and the cumulative power LF+HF, respectively,
[21, 22].
In addition, the ratio of low-frequency (LF) to high-fre-
quencymodulation (HF) of the RR intervals which is consid-
ered to be an indirect marker of the sympathovagal balance
(LF/HF) was also assessed [7]. All the software code was
written in Matlab 7.10.
2.5. Data Analysis and Statistics. AP data were stored and
analyzed by a computerized on line system for biological data
elaboration developed in our laboratory based on a Lab view
platform software.
Within groups changes in the reported variables were
evaluated by one-way ANOVA for repeatedmeasures for nor-
mally distributed variables and by Kruskal-Wallis one way
ANOVA on Ranks for nonnormally distributed variables.
The significance of differences of baseline values between the
two experimental groups was evaluated by t-test. All data are
Table 1: Comparison of cardiovascular and autonomic values
in baseline (i.e., before intratracheal instillation of either PBS or
SWCNTs) condition between control and SWCNT instilled rats.
Control (n = 7) Instilled (n = 9)
SAP (mmHg) 130.7± 5.1 127.2± 5.0 NS
DAP (mmHg) 99.9± 4.4 95.8± 3.2 NS
HR (b/min) 333.1± 17.0 351.6± 12.0 NS
BARO% 8.3± 0.7 7.5± 0.5 NS
BRS (msec/mmHg) 4.1± 0.9 3.5± 0.6 NS
NBARO% 4.1± 0.5 3.9± 0.2 NS
NBRS (msec/mmHg) 4.1± 0.9 3.4± 0.5 NS
Mean values ± SEM. SAP: systolic arterial pressure; DAP: diastolic
arterial pressure; HR: heart rate; BARO%: engagement time for baroreflex
sequences; BRS: baroreflex sensitivity; NBARO%: engagement time for
nonbaroreflex sequences; NBRS: gain of the nonbaroreflex sequences.
Statiscal analysis has been performed by one-way repeated measures analysis
of variance or Friedman repeated measures analysis of variance on ranks
tests.
presented as means ± SEM. A value of P < 0.05 was con-
sidered statistically significant.
3. Results
In baseline conditions (i.e., before intratracheal instillation
of either PBS or SWCNTs) cardiovascular parameters did not
differ between control and SWCNT instilled rats (Table 1)
and no significant cardiovascular changes were evident after
24 hours (Figure 3) in both experimental groups.
Similarly the occurrence of baroreflex sequences and BRS
in baseline conditions did not show significant changes bet-
ween control and SWCNT instilled rats (Table 1). Also the
indexes evaluating the spectral analysis of the heart rate
variability were similar in baseline condition between the two
experimental groups and in particular LFn was 0, 079± 0, 01
for control group and 0, 066 ± 0, 009 for SWCNT instilled
rats, HFn 0, 402 ± 0, 06 versus 0, 261 ± 0, 05, VLFn 0, 519 ±
0, 07 versus 0, 673± 0, 05, and LFn/HFn 0, 209± 0, 02 versus
0, 342± 0, 07.
The power spectral analysis of the heart rate variability
did not appear to be affected by the SWCNT experimental
acute exposure. In fact LFn, HFn, VLFn, LFn/HFn did not
show significant changes between basal condition and after
24 hour from the instillation both in the control and in the
SWCNT instilled rats (Figure 4).
In the control group the PBS instillation did not induce
any significant changes in the occurrence and in the sensi-
tivity of baroreflex sequences (Figure 5). At variance the
SWCNT experimental acute exposure induced a significant
reduction of BRS without significant changes in the occur-
rence of baroreflex sequences (Figure 5). These differences
are not trivial because whereas in SWCNT instilled rats the
significant reduction accounts about 21% for BRS, in the
control group BRS shows an increase of about 51%. Indeed
the BRS percent changes from baseline versus acute exposure
are significantly different between PBS and SWCNT instilled
rats (Figure 6).
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Figure 3: Systolic (SAP), diastolic (DAP) arterial pressure, and RR interval values before and after acute instillation of, respectively, PBS
(control group) and SWCNTs (experimental group).
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Figure 4: Differences in the frequency domain indexes of heart rate variability obtained by computing the power spectral density (see
Section 2 for the details) in response to acute instillation of, respectively, PBS (control group) and SWCNTs (experimental group). LFn: low
frequency values expressed in normalized units; HFn: high frequency values expressed in normalized units; VLFn: very low frequency values
expressed in normalized units; LFn/HFn: the ratio of normalized low-frequency (LF) to high-frequency modulation (HF) of the RR intervals
which is considered to be an indirect marker of the sympathovagal balance (LFn/HFn).
The mean prevailing systolic arterial pressure determin-
ing the operating point at which the baroreflex and non-
baroreflex sequences were calculated did not differ signifi-
cantly after the instillation both in the control and in the
experimental group (127,2mmHg in baseline condition ver-
sus 121,9mmHg after SWCNT instillation and 130,7mmHg
in baseline condition versus 127,4mmHg after the instilla-
tion in control group).
4. Discussion
The main goal of the present investigation was to study the
autonomic cardiovascular regulation in response to acute
pulmonary exposure to carbon nanotubes. The distinctive
aspect of the present study has been to utilize a physiological
model of conscious freely moving rats in order to avoid any
possible and well known interference of anesthetic drugs
6 Journal of Nanomaterials
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PBS (control group) and SWCNTs (experimental group) from base-
line values. Asterisk indicates a significant difference (P < 0.05).
and other experimental tools routinarily used in acute expe-
rimental models.
It has been largely reported that airborne particulate
matter (PM) is associated with cardiovascular diseases and in
particular with acute events thus increasing the ED visits [8].
Moreover UF particles seem to cause an alteration of the car-
diovascular autonomic regulation [10]. Less data exist con-
cerning the effect of synthetic nanomaterials even though
their size is similar to UF particles. In particular the attractive
properties of nanomaterials for medical and technologi-
cal applications induces an increase in their utilizations and
therefore a growing level of possible exposure to these mate-
rials.
Concerning the cardiovascular system, previous studies
have shown that carbon nanotubes have the potential effect
of promoting atherosclerosis [11].
Our study shows for the first time that acute pulmonary
exposure to SWCNTs causes a reduction of BRS in conscious
freely moving rats.
Infact in the control group PBS instillation induced a
non significant increase in BRS whereas in the experimental
group SWCNT instillation produced a significant BRS reduc-
tion. Even when considered as percent change from control
values, the responses to PBS and to SWCNTs resulted sig-
nificantly different despite the relevant data dispersion as
demonstrated by SEM (Figure 6).
In the intact circulation beat-by-beat spontaneous arte-
rial pressure fluctuations have been shown to be linked to
beat-by-beat spontaneous changes in RR interval through
baroreflex mechanisms. On this basis the “sequence” tech-
nique [23] is able to extract from SAP and RR time series
sequences of spontaneously occurring consecutive beats in
which SAP and RR of the following beat change in the same
direction, that is hypertensive/bradycardic (SAP+/RR+) and
hypotensive/tachycardic sequences (SAP−/RR−). These seq-
uences have been named “baroreflex sequences” and have
been considered as expression of negative feedback mecha-
nisms of baroreflex origin [2] (Figure 2).
The introduction of techniques able to monitor arterial
pressure and heart rate in conscious freely moving animals
allows to evaluate possible modifications of autonomic car-
diovascular regulation over time in response to various
experimental conditions [12]. In particular, the possibility
to monitor the baroreflex control of sinus node by study-
ing the baroreflex sensitivity (BRS), in a noninvasive and
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nonobtrusive way [13] is really intriguing due to its prog-
nostic value in cardiovascular diseases [15]. Indeed a pilot
study from our group suggested the feasibility to evaluate the
arterial baroreflex function [24] in response to SWCNT pul-
monary exposure in conscious freely moving rats. Moreover,
autonomic cardiovascular regulation has been investigated
by means of power spectral analysis of HR and BP variability,
a technique currently used to derive noninvasive indexes of
the different neural components modulating the sinoatrial
node and the autonomic vascular outflow [7].
The possibility to analyze the cardiovascular autonomic
pattern and in particular the arterial baroreflex function is
relevant because it has been widely shown that alteration
in the autonomic modulation of the cardiovascular system
has an important prognostic and predictive value in patients
affected by cardiovascular disease. In particular several stud-
ies have indicated that a depressed BRS, an index of the reflex
vagal control of the sinus node is associated with a greater
risk for ventricular fibrillation during transient ischemia
after myocardial infarction [25, 26]. The unfavorable effect
of a depressed BRS on ventricular arrhythmias during myo-
cardial ischemia also extends to animals without prior myo-
cardial infarction [26]. Moreover, clinical studies have clearly
demonstrated that BRS is markedly depressed during spon-
taneous episodes of transient myocardial ischemia [27] and
in patients without a myocardial infarction who experienced
out-of-hospital ventricular fibrillation [28].
Therefore the possibility that the reduced BRS in res-
ponse to SWCNT acute exposure, shown in the present study,
might contribute to the increased cardiovascular risk con-
nected to high levels of airborne particulate matter, as con-
stituted both by PM and UF matter, must be taken into
account. Indeed increased levels of environmental UF partic-
ulate have been reported to be linked to increased ED access
for cardiac arrhythmias [8].
It is noteworthy that the power spectral analysis has not
shown significant changes in response to acute SWCNT ex-
posure. This is an important information, because BRS and
power spectral analysis, as tools to extract physiological in-
formation from the heart rate variability, reflect different,
although possibly related [29], aspects of the autonomic
modulation of the heart rate and are not clinically redundant
[15, 30]. Although both BRS and heart rate variability effec-
tively discriminate individuals at high and low risk for car-
diac mortality [15], experimental [31], and clinical [32–34]
studies have indicated that BRS is more useful in the predic-
tion of future cardiac events in patients affected by ischemic
cardiac disease. Another possible alternative explanation is
that our analysis has been performed on 5-min intervals,
a time in which is possible to evaluate only the short-term
HRV thus loosing information that could be present in the
whole-time interval. Furthermore, it must be pointed out
that power spectral analysis is a tool belonging to the field of
the so-called linear analysis and does not take into account
possible nonlinear variations occurring between the two
conditions.
Overall these data might suggest that the autonomic car-
diovascular regulation is affected by acute SWCNT exposure
by acting on the negative feedback mechanisms of baroreflex
origin, mainly vagally mediated. These data may have rele-
vance from an occupational perspective. In fact, given the
expected widespread production of CNTs-based goods, an
accidental exposure at work may be considered possible. Not
surprisingly, case-reports, regarding adverse outcomes after
accidental exposure to manufactured nanomaterials are
starting to be reported [35–37]. Another point to be con-
sidered is that a substantial amount of workers have chronic
cardiovascular disorders: these workers are highly sensitive to
the adverse effects of altered cardiac autonomic regulation,
and thus the effects observed in this experimental study
might be seen at corresponding lower doses and might also
be more severe than those reported here.
In conclusion, the results of the present study show that
SWCNT pulmonary exposure might alter the physiological
autonomic regulation thus contributing to cardiac and ar-
rhythmic events as reported in response to PM and UF par-
ticles exposure.
Limitation. The generalization of the BRS response to
SWCNT exposure to the whole population including also
patients affected by cardiovascular diseases and in particular
ischemic cardiac disease represents a limitation of this study.
Therefore, it would be desirable to extend the present study
to an animal model of experimentally induced myocardial
infarction in order to test the hypothesis that the BRS dep-
ression induced by SWCNT exposure might also occur in
patients affected by myocardial infarction.
However, considering that it has been clearly reported by
clinical studies that both BRS and heart rate variability are
reduced after a myocardial infarction [14] and that BRS is
markedly depressed during spontaneous episodes of tran-
sient myocardial ischemia [27] and in patients without˜a
myocardial infarction who experienced out-of-hospital ven-
tricular fibrillation [28], it is conceivable that an eventual
BRS reduction in response to SWCNT exposure in patients
affected by ischemic cardiac disease might represent an
environmental risk factor for developing life-threatening ar-
rhythmic events.
Also the limited experimental sample reported in the pre-
sent study might have biased some results. For this reason
further experiments are needed to definitively confirm our
findings.
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